91 related articles for article (PubMed ID: 3972727)
1. Vanoxonin, a new inhibitor of thymidylate synthetase. III. Inhibition of thymidylate synthetase by vanoxonin-vanadium complex.
Kanai F; Kaneko T; Morishima H; Isshiki K; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):39-50. PubMed ID: 3972727
[TBL] [Abstract][Full Text] [Related]
2. Vanoxonin, a new inhibitor of thymidylate synthetase.
Kanai F; Sawa T; Hamada M; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Jun; 36(6):656-60. PubMed ID: 6874588
[TBL] [Abstract][Full Text] [Related]
3. Vanoxonin, a new inhibitor of thymidylate synthetase. II. Structure determination and total synthesis.
Kanai F; Isshiki K; Umezawa Y; Morishima H; Naganawa H; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):31-8. PubMed ID: 3972726
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mammalian tumour thymidylate synthetase by 5-alkylated 2'-deoxyuridine 5'-phosphates.
Rode W; Kulikowski T; Kedzierska B; Jastreboff M; Shugar D
Biochem Pharmacol; 1984 Sep; 33(17):2699-705. PubMed ID: 6466380
[TBL] [Abstract][Full Text] [Related]
5. 5-Cyano-2'-deoxyuridine 5'-phosphate: a potent competitive inhibitor of thymidylate synthetase.
Chang CT; Edwards MW; Torrence PF; Mertes MP
J Med Chem; 1979 Sep; 22(9):1137-9. PubMed ID: 114660
[TBL] [Abstract][Full Text] [Related]
6. Synthetic inhibitors of Escherichia coli, calf thymus, and Ehrlich ascites tumor thymidylate synthetase.
Kampf A; Barfknecht RL; Shaffer PJ; Osaki S; Mertes MP
J Med Chem; 1976 Jul; 19(7):903-8. PubMed ID: 781246
[TBL] [Abstract][Full Text] [Related]
7. trans-5-(3,3,3-Trifluoro-1-propenyl-)-2'-deoxyuridylate: a mechanism-based inhibitor of thymidylate synthetase.
Wataya Y; Matsuda A; Santi DV; Bergstrom DE; Ruth JL
J Med Chem; 1979 Apr; 22(4):339-40. PubMed ID: 430474
[No Abstract] [Full Text] [Related]
8. 5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
Maggiora L; Chang CT; Hasson ME; Bigge CF; Mertes MP
J Med Chem; 1983 Jul; 26(7):1028-36. PubMed ID: 6408258
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Lactobacillus casei thymidylate synthetase by 5-substituted 2'-deoxyuridylates. Preliminary quantitative structure-activity relationship.
Wataya Y; Santi DV; Hansch C
J Med Chem; 1977 Nov; 20(11):1469-73. PubMed ID: 410930
[No Abstract] [Full Text] [Related]
10. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells.
Jackson RC; Jackman AL; Calvert AH
Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
Jackman AL; Calvert AH; Hart LI; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
[No Abstract] [Full Text] [Related]
12. Inhibition of thymidylate synthetase of the human lymphocytes.
Haurani FI
Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis and quantitative structure-activity relationships. Inhibition of dihydrofolate reductase and thymidylate synthetase by quinazolines.
Chen BK; Horváth C; Bertino JR
J Med Chem; 1979 May; 22(5):483-91. PubMed ID: 110930
[TBL] [Abstract][Full Text] [Related]
14. Human thymidylate synthetase--III. Effects of methotrexate and folate analogs.
Szeto DW; Cheng YC; Rosowsky A; Yu CS; Modest EJ; Piper JR; Temple C; Elliott RD; Rose JD; Montgomery JA
Biochem Pharmacol; 1979 Sep; 28(17):2633-7. PubMed ID: 518674
[No Abstract] [Full Text] [Related]
15. Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells.
Jastreboff MM; Kedzierska B; Rode W
Biochem Pharmacol; 1983 Jul; 32(14):2259-67. PubMed ID: 6223641
[TBL] [Abstract][Full Text] [Related]
16. Interaction of 1-(5-phospho-beta-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-beta-D-arabinosyl)-5-fluorouracil.
Nakayama C; Wataya Y; Santi DV; Saneyoshi M; Ueda T
J Med Chem; 1981 Oct; 24(10):1161-5. PubMed ID: 7328576
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
[TBL] [Abstract][Full Text] [Related]
18. Properties of thymidylate synthetase from Ehrlich ascites carcinoma cells. Effect of Mg2/ and MgATP2-.
Jastreboff M; Kedzierska B; Rode W
Biochem Pharmacol; 1982 Jan; 31(2):217-23. PubMed ID: 6977362
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthetase inhibitors. Synthesis of N-substituted 5-aminomethyl-2'-deoxyuridine 5'-phosphates.
Edelman MS; Barfknecht RL; Huet-Rose R; Boguslawski S; Mertes MP
J Med Chem; 1977 May; 20(5):669-73. PubMed ID: 323484
[TBL] [Abstract][Full Text] [Related]
20. 5(E)-(3-azidostyryl)-2'-deoxyuridine 5'-phosphate is a photoactivated inhibitor of thymidylate synthetase.
De Clercq E; Balzarini J; Chang CT; Bigge CF; Kalaritis P; Mertes MP
Biochem Biophys Res Commun; 1980 Dec; 97(3):1068-75. PubMed ID: 7470133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
